Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Arch Soc Esp Oftalmol (Engl Ed) ; 93(1): 38-41, 2018 Jan.
Article in English, Spanish | MEDLINE | ID: mdl-28624313

ABSTRACT

CASE REPORT: The case involves a 35-year-old man, with a history of retinitis pigmentosa, who presented with a bilateral cystoid macular oedema associated with bilateral epiretinal membrane, which was resistant to treatment with oral acetazolamide and intravitreal bevacizumab. The treatment with oral eplerenone was able to improve the visual acuity and macular thickness of this patient. DISCUSSION: A variety of treatments have been proposed for the management of cystoid macular oedema, associated with retinitis pigmentosa, with variable results. The treatment with oral eplerenone might be a good option for the control of this condition.


Subject(s)
Eplerenone/therapeutic use , Macular Edema/drug therapy , Retinitis Pigmentosa/drug therapy , Adult , Humans , Macular Edema/complications , Male , Retinitis Pigmentosa/complications
2.
Arch Soc Esp Oftalmol ; 92(10): 477-480, 2017 Oct.
Article in English, Spanish | MEDLINE | ID: mdl-28651811

ABSTRACT

CASE REPORT: A 45 year-old man with a history of adrenal phaeochromocytoma presented with a subretinal juxtapapillary haemorrhage on his left eye and a small asymptomatic vascular tumour in the contralateral eye. With the mentioned findings, the patient was diagnosed with bilateral retinal capillary haemangioma in the context of a von Hippel Lindau disease. Intravitreal aflibercept was prescribed, with a good outcome of the disease. DISCUSSION: Many treatments have been proposed for the management of juxtapapillary retinal capillary haemangioma with variable results. Intravitreal aflibercept can be a useful treatment with a good safety profile.


Subject(s)
Angiogenesis Inhibitors/therapeutic use , Hemangioma, Capillary/complications , Neoplasms, Multiple Primary/diagnosis , Receptors, Vascular Endothelial Growth Factor/therapeutic use , Recombinant Fusion Proteins/therapeutic use , Retinal Hemorrhage/drug therapy , Retinal Neoplasms/complications , Adrenal Gland Neoplasms , Angiogenesis Inhibitors/administration & dosage , Fluorescein Angiography , Hemangioma, Capillary/diagnostic imaging , Humans , Intravitreal Injections , Male , Middle Aged , Neoplasms, Multiple Primary/diagnostic imaging , Neoplasms, Multiple Primary/genetics , Pheochromocytoma , Receptors, Vascular Endothelial Growth Factor/administration & dosage , Recombinant Fusion Proteins/administration & dosage , Retinal Hemorrhage/etiology , Retinal Neoplasms/diagnosis , Retinal Neoplasms/diagnostic imaging , Retinal Neoplasms/genetics , Tomography, Optical Coherence , von Hippel-Lindau Disease/complications , von Hippel-Lindau Disease/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...